Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers By Ogkologos - April 9, 2026 114 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the real-world study conducted by the Netherlands Cancer Institute Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR FDA Approves Oral Combination of Decitabine and Cedazuridine for Myelodysplastic Syndromes July 14, 2020 ESMO awards its first fellowship to support digital and computational pathology September 10, 2025 FDA Approves Lurbinectedin in Combination with Atezolizumab or Atezolizumab and Hyaluronidase-tqjs... October 16, 2025 ESMO Manifesto – Translating Scientific Evidence Into Effective Public Health Policy October 20, 2023 Load more HOT NEWS Telisotuzumab Vedotin Associated with Durable Responses in c-Met Protein–Overexpressing Non-Squamous EGFR-wild-type... FDA Approves Nivolumab with Chemotherapy for Previously Untreated Hodgkin Lymphoma FDA Approves Alpelisib for PIK3CA-Related Overgrowth Spectrum Young Women At Increased Risk Of Aggressive Breast Cancer
